Risk Factors of Total Anomalous Pulmonary Venous Connection Surgery

作者
Chi-Lun Wu,Chung‐Dann Kan,Jing‐Ming Wu,Jieh‐Neng Wang
出处
期刊:Pediatric & health research [Scitechnol Biosoft Pvt. Ltd (OMICS)]
卷期号:01 (01) 被引量:4
标识
DOI:10.21767/2574-2817.100003
摘要

Background: Total anomalous pulmonary venous connection is a rare congenital heart disease that needs to be surgically corrected. In our study, we retrospectively evaluated the factors associated with mortality and morbidity in patients undergoing total anomalous pulmonary venous connection surgery. Patients and methods: Retrospective data were collected on 34 patients with isolated total anomalous pulmonary venous connection seen from 1990 to 2015. The median age at time of repair was 36 days (range, 1 to 2520 days) with median weight of 3.465 kg (range, 1.4 to 20.7 kg). Pulmonary venous obstruction, reintervention, associated factors for mortality and overall mortality were recorded and analyzed. Results: There were 16 deaths (13 surgical deaths and 3 late deaths due to pulmonary venous restenosis and reintervention). Preoperative pulmonary venous obstruction was presented in 21 patients (21/34, 61.8%) and was found to be associated with overall mortality (p=0.0052). Postoperative pulmonary venous restenosis was also a significant risk factor for mortality (p=0.0421). Emergent surgery is a risk factor for mortality (p=0.004). The associated risk factors, such as pre-operation ventilator FiO2, pre-operation inotropic use, postoperation ventilator FiO2 and post-operation epinephrine use were also associated with patient mortality. The initial SpO2 when arriving at our hospital was a protective factor for mortality. Conclusion: The overall mortality of total anomalous pulmonary venous connection patients has improved in recent years. However, preoperative pulmonary venous obstruction was still an important risk factor for mortality. Postoperative pulmonary venous restenosis was also a risk factor for mortality. Heart failure and emergent surgery were associated with higher mortality rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
www0717完成签到,获得积分10
刚刚
刚刚
魏子合完成签到 ,获得积分10
1秒前
阿呆完成签到,获得积分10
1秒前
zhangxin完成签到,获得积分10
2秒前
lin完成签到,获得积分10
2秒前
风清扬的应助被软嘴唇采纳,获得10
2秒前
fdj3121完成签到,获得积分10
2秒前
Lincoln完成签到,获得积分10
2秒前
2秒前
rl完成签到,获得积分10
3秒前
符驳完成签到,获得积分10
3秒前
xzn1123完成签到,获得积分0
3秒前
小林子完成签到,获得积分10
3秒前
从容的犀牛完成签到,获得积分10
3秒前
3秒前
黄婷完成签到,获得积分10
4秒前
曾经安萱完成签到,获得积分10
5秒前
Chris完成签到 ,获得积分10
5秒前
搜集达人的应助被温柔的可愁采纳,获得30
6秒前
曹国庆完成签到 ,获得积分0
6秒前
地动完成签到 ,获得积分10
7秒前
忐忑的小玉完成签到,获得积分0
7秒前
傲娇的秋莲完成签到,获得积分10
7秒前
诚心巧曼发布了新的文献求助10
9秒前
科研人完成签到,获得积分10
9秒前
HJJHJH完成签到,获得积分20
9秒前
大树完成签到,获得积分10
9秒前
李丙首完成签到,获得积分10
10秒前
上官若男的应助被Mia采纳,获得10
11秒前
科目三的应助被学术流浪汉采纳,获得10
11秒前
wanci的应助被胖罐子采纳,获得10
12秒前
JuliaLee发布了新的文献求助20
12秒前
JXDYYZK完成签到,获得积分0
12秒前
聪明的慕儿完成签到,获得积分10
12秒前
勤恳的曼凡完成签到 ,获得积分10
13秒前
初景发布了新的文献求助100
13秒前
cx完成签到,获得积分10
15秒前
kunkun完成签到,获得积分10
15秒前
Blueyi完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Sustainable Engineered Micro/Nanofibers and Hybrid Nanocomposites for Environmental Remediation 400
Ecotourism 400
Liquidus diagram and viscosity estimation in pseudo-binary system Li2B6O10–LiF 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8076236
求助须知:如何正确求助?哪些是违规求助? 9494346
关于积分的说明 21379164
捐赠科研通 7644285
什么是DOI,文献DOI怎么找? 3400025
关于科研通互助平台的介绍 2529836
邀请新用户注册赠送积分活动 2438732